Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process is made as efficient as possible. The 11th CMR Workshop, held in September 1995, provided the opportunity for regulatory authority and industry personnel from Europe, North America, Australia and Japan to openly discuss views and exchange experiences on the subject of improving the review process. The proceedings of this meeting provide a comprehensive overview of the current review process around the world. The contributors describe the present situation and highlight company strategies and regulatory initiatives to improve the review process. This volume also summarises the suggestions that were developed by the participants, covering many facets of this process, including the quality and size of the dossier, dialogue, submission strategies, feedback and the response to questions.
"synopsis" may belong to another edition of this title.
Shipping:
US$ 10.48
From United Kingdom to U.S.A.
Shipping:
FREE
Within U.S.A.
Seller: WeBuyBooks, Rossendale, LANCS, United Kingdom
Condition: UNSPECIFIED. Most items will be dispatched the same or the next working day. Seller Inventory # wbs8265128433
Quantity: 1 available
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: NEW. Seller Inventory # 9780792387060
Quantity: 10 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: NEW. Seller Inventory # 1675587-n
Quantity: 5 available
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: NEW. Seller Inventory # ABLIING23Feb2416190185481
Quantity: Over 20 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: NEW. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780792387060_lsuk
Quantity: Over 20 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: USED_ASNEW. Unread book in perfect condition. Seller Inventory # 1675587
Quantity: 5 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: NEW. Seller Inventory # 1675587-n
Quantity: 5 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: NEW. This item is printed on demand - it takes 3-4 days longer - Neuware -Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process is made as efficient as possible. The 11th CMR Workshop, held in September 1995, provided the opportunity for regulatory authority and industry personnel from Europe, North America, Australia and Japan to openly discuss views and exchange experiences on the subject of improving the review process. The proceedings of this meeting provide a comprehensive overview of the current review process around the world. The contributors describe the present situation and highlight company strategies and regulatory initiatives to improve the review process. This volume also summarises the suggestions that were developed by the participants, covering many facets of this process, including the quality and size of the dossier, dialogue, submission strategies, feedback and the response to questions. 196 pp. Englisch. Seller Inventory # 9780792387060
Quantity: 2 available
Seller: moluna, Greven, Germany
Gebunden. Condition: NEW. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is . Seller Inventory # 5971091
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: NEW. Druck auf Anfrage Neuware - Printed after ordering - Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process is made as efficient as possible. The 11th CMR Workshop, held in September 1995, provided the opportunity for regulatory authority and industry personnel from Europe, North America, Australia and Japan to openly discuss views and exchange experiences on the subject of improving the review process. The proceedings of this meeting provide a comprehensive overview of the current review process around the world. The contributors describe the present situation and highlight company strategies and regulatory initiatives to improve the review process. This volume also summarises the suggestions that were developed by the participants, covering many facets of this process, including the quality and size of the dossier, dialogue, submission strategies, feedback and the response to questions. Seller Inventory # 9780792387060
Quantity: 1 available